Back to DS Daiwa Securities Group Inc.
SMMT
Showing 6 of 22 quarters
Position history for DSDaiwa Securities Group Inc.'s holdings in Summit Therapeutics Inc.
No. Daiwa Securities Group exited its SMMT (Summit Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 2,157 shares worth $38,000. Daiwa Securities Group first reported SMMT in Q4 2020 and held it in 21 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$43,000
Total Shares Change
-2,434
Quarter-by-Quarter History